Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer

This study has been completed.
Sponsor:
Collaborators:
North Florida Foundation for Research and Education
Axcan Pharma
Information provided by (Responsible Party):
Unyime O. Nseyo, MD, North Florida/South Georgia Veterans Health System
ClinicalTrials.gov Identifier:
NCT00322699
First received: May 4, 2006
Last updated: October 25, 2012
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)